Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

被引:440
作者
Akolekar, Ranjit [2 ,4 ]
Syngelaki, Argyro [2 ,3 ,4 ]
Poon, Leona [2 ]
Wright, David [1 ]
Nicolaides, Kypros H. [2 ,3 ]
机构
[1] Univ Plymouth, Sch Comp & Math, Plymouth PL4 8AA, Devon, England
[2] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London SE5 9RS, England
[3] Univ Coll London Hosp, Dept Fetal Med, London, England
[4] Medway Maritime Hosp, Dept Fetal Med, Gillingham, England
关键词
First-trimester screening; Preeclampsia; Uterine artery Doppler; Mean arterial pressure; Placental growth factor; Pyramid of pregnancy care; PLACENTAL GROWTH-FACTOR; HYPERTENSIVE DISORDERS; PREDICTION; GESTATION; PREGNANCY; PREVENTION; TRISOMY-21; ASPIRIN;
D O I
10.1159/000341264
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To develop models for prediction of preeclampsia (PE) based on maternal characteristics, biophysical and biochemical markers at 11-13 weeks' gestation in which the gestation at the time of delivery for PE is treated as a continuous variable. Methods:This was a screening study of singleton pregnancies at 11-13 weeks including 1,426 (2.4%) that subsequently developed PE and 57,458 that were unaffected by PE. We developed a survival time model for the time of delivery for PE in which Bayes' theorem was used to combine the prior information from maternal characteristics with uterine artery pulsatility index (PI), mean arterial pressure (MAP), serum pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PLGF) multiple of the median (MoM) values. Results: In pregnancies with PE, there was a linear correlation between MoM values of uterine artery PI, MAP, PAPP-A and PLGF with gestational age at delivery and therefore the deviation from normal was greater for early than late PE for all four biomarkers. Screening by maternal characteristics, biophysical and biochemical markers detected 96% of cases of PE requiring delivery before 34 weeks and 54% of all cases of PE at a fixed false-positive rate of 10%. Conclusions: A new model has been developed for effective first-trimester screening for PE. copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:8 / 15
页数:8
相关论文
共 28 条
[1]   Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia [J].
Akolekar, R. ;
Zaragoza, E. ;
Poon, L. C. Y. ;
Pepes, S. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2008, 32 (06) :732-739
[2]   Maternal Plasma P-selectin at 11 to 13 Weeks of Gestation in Hypertensive Disorders of Pregnancy [J].
Akolekar, Ranjit ;
Veduta, Alina ;
Minekawa, Ryoko ;
Chelemen, Teodora ;
Nicolaides, Kypros H. .
HYPERTENSION IN PREGNANCY, 2011, 30 (03) :311-321
[3]   Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks [J].
Akolekar, Ranjit ;
Syngelaki, Argyro ;
Sarquis, Rita ;
Zvanca, Mona ;
Nicolaides, Kypros H. .
PRENATAL DIAGNOSIS, 2011, 31 (01) :66-74
[4]   Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia [J].
Akolekar, Ranjit ;
Syngelaki, Argyro ;
Beta, Jarek ;
Kocylowski, Rafal ;
Nicolaides, Kypros H. .
PRENATAL DIAGNOSIS, 2009, 29 (12) :1103-1108
[5]   Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy [J].
Akolekar, Ranjit ;
Casagrandi, Davide ;
Livanos, Panagiotis ;
Tetteh, Amos ;
Nicolaides, Kypros H. .
PRENATAL DIAGNOSIS, 2009, 29 (10) :934-938
[6]   Maternal Serum Activin A at 11-13 Weeks of Gestation in Hypertensive Disorders of Pregnancy [J].
Akolekar, Ranjit ;
Etchegaray, Adolfo ;
Zhou, Yi ;
Maiz, Nerea ;
Nicolaides, Kypros H. .
FETAL DIAGNOSIS AND THERAPY, 2009, 25 (03) :320-327
[7]   Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy [J].
Akolekar, Ranjit ;
Minekawa, Ryoko ;
Veduta, Alina ;
Romero, Ximena C. ;
Nicolaides, Kypros H. .
PRENATAL DIAGNOSIS, 2009, 29 (08) :753-760
[8]  
[Anonymous], CONF ENQ MAT CHILD H
[9]   The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) [J].
Brown, MA ;
Lindheimer, MD ;
de Swiet, M ;
Van Assche, A ;
Moutquin, JM .
HYPERTENSION IN PREGNANCY, 2001, 20 (01) :IX-XIV
[10]   Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy A Meta-Analysis [J].
Bujold, Emmanuel ;
Roberge, Stephanie ;
Lacasse, Yves ;
Bureau, Marc ;
Audibert, Francois ;
Marcoux, Sylvie ;
Forest, Jean-Claude ;
Giguere, Yves .
OBSTETRICS AND GYNECOLOGY, 2010, 116 (02) :402-414